Extendicare Inc. (EXETF)
USD 9.23
(0.33%)
USD 9.23
(0.33%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 259.33 Million CAD | 19.68% |
| 2022 | 216.69 Million CAD | -49.87% |
| 2021 | 432.22 Million CAD | 12.37% |
| 2020 | 384.64 Million CAD | -16.27% |
| 2019 | 459.4 Million CAD | -0.3% |
| 2018 | 460.78 Million CAD | 12.96% |
| 2017 | 407.91 Million CAD | 1.47% |
| 2016 | 401.98 Million CAD | 14.71% |
| 2015 | 350.45 Million CAD | -20.98% |
| 2014 | 443.49 Million CAD | -58.51% |
| 2013 | 1.06 Billion CAD | 0.75% |
| 2012 | 1.06 Billion CAD | -6.49% |
| 2011 | 1.13 Billion CAD | -7.22% |
| 2010 | 1.22 Billion CAD | -0.92% |
| 2009 | 1.23 Billion CAD | 2.01% |
| 2008 | 1.2 Billion CAD | 17.74% |
| 2007 | 1.02 Billion CAD | 24.83% |
| 2006 | 823.12 Million CAD | 8.57% |
| 2005 | 758.13 Million CAD | 63.14% |
| 2004 | 464.7 Million CAD | -31.93% |
| 2003 | 682.65 Million CAD | -20.36% |
| 2002 | 857.13 Million CAD | 5.5% |
| 2001 | 812.42 Million CAD | -1.58% |
| 2000 | 825.44 Million CAD | -11.59% |
| 1999 | 933.68 Million CAD | -10.8% |
| 1998 | 1.04 Billion CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 188.87 Million CAD | -20.89% |
| 2024 Q1 | 238.75 Million CAD | -7.94% |
| 2023 Q2 | 310.69 Million CAD | 6.59% |
| 2023 Q4 | 259.33 Million CAD | 6.71% |
| 2023 Q1 | 291.48 Million CAD | 34.51% |
| 2023 FY | 259.33 Million CAD | 19.68% |
| 2023 Q3 | 243.02 Million CAD | -21.78% |
| 2022 Q4 | 216.69 Million CAD | 9.63% |
| 2022 FY | 216.69 Million CAD | -49.87% |
| 2022 Q1 | 248.61 Million CAD | -42.48% |
| 2022 Q3 | 197.66 Million CAD | 46.31% |
| 2022 Q2 | 135.09 Million CAD | -45.66% |
| 2021 Q2 | 418.7 Million CAD | 0.39% |
| 2021 Q3 | 413.17 Million CAD | -1.32% |
| 2021 Q4 | 432.22 Million CAD | 4.61% |
| 2021 Q1 | 417.1 Million CAD | 8.44% |
| 2021 FY | 432.22 Million CAD | 12.37% |
| 2020 Q4 | 384.64 Million CAD | -4.12% |
| 2020 FY | 384.64 Million CAD | -16.27% |
| 2020 Q3 | 401.16 Million CAD | -11.9% |
| 2020 Q2 | 455.36 Million CAD | 1.52% |
| 2020 Q1 | 448.54 Million CAD | -2.88% |
| 2019 Q1 | 462.29 Million CAD | -0.17% |
| 2019 FY | 459.4 Million CAD | -0.3% |
| 2019 Q2 | 473.93 Million CAD | 2.52% |
| 2019 Q3 | 462.12 Million CAD | -2.49% |
| 2019 Q4 | 461.84 Million CAD | -0.06% |
| 2018 Q1 | 415.64 Million CAD | 1.9% |
| 2018 Q3 | 456.44 Million CAD | 0.46% |
| 2018 Q4 | 463.07 Million CAD | 1.45% |
| 2018 FY | 460.78 Million CAD | 12.96% |
| 2018 Q2 | 454.35 Million CAD | 9.31% |
| 2017 Q2 | 396.85 Million CAD | -1.45% |
| 2017 Q4 | 407.91 Million CAD | 2.03% |
| 2017 FY | 407.91 Million CAD | 1.47% |
| 2017 Q1 | 402.68 Million CAD | 0.17% |
| 2017 Q3 | 399.8 Million CAD | 0.74% |
| 2016 Q2 | 407.9 Million CAD | 0.26% |
| 2016 FY | 401.98 Million CAD | 14.71% |
| 2016 Q4 | 401.98 Million CAD | -2.39% |
| 2016 Q3 | 411.84 Million CAD | 0.97% |
| 2016 Q1 | 406.84 Million CAD | 16.09% |
| 2015 Q1 | 426.75 Million CAD | -3.77% |
| 2015 Q4 | 350.45 Million CAD | 30.88% |
| 2015 Q3 | 267.76 Million CAD | -32.46% |
| 2015 Q2 | 396.42 Million CAD | -7.11% |
| 2015 FY | 350.45 Million CAD | -20.98% |
| 2014 Q1 | 1.06 Billion CAD | -0.12% |
| 2014 FY | 443.49 Million CAD | -58.51% |
| 2014 Q3 | 1.07 Billion CAD | 2.33% |
| 2014 Q4 | 443.49 Million CAD | -58.64% |
| 2014 Q2 | 1.04 Billion CAD | -1.85% |
| 2013 Q1 | 1.07 Billion CAD | -5.23% |
| 2013 Q3 | 1.05 Billion CAD | -3.69% |
| 2013 Q4 | 1.06 Billion CAD | 1.14% |
| 2013 FY | 1.06 Billion CAD | 0.75% |
| 2013 Q2 | 1.09 Billion CAD | 2.25% |
| 2012 Q1 | 1.1 Billion CAD | -2.32% |
| 2012 Q3 | 1.02 Billion CAD | -1.06% |
| 2012 Q4 | 1.13 Billion CAD | 10.01% |
| 2012 FY | 1.06 Billion CAD | -6.49% |
| 2012 Q2 | 1.04 Billion CAD | -6.12% |
| 2011 Q3 | 1.24 Billion CAD | 30.33% |
| 2011 Q4 | 1.13 Billion CAD | -8.95% |
| 2011 FY | 1.13 Billion CAD | -7.22% |
| 2011 Q1 | 1.23 Billion CAD | 0.97% |
| 2011 Q2 | 955.98 Million CAD | -22.56% |
| 2010 Q4 | 1.22 Billion CAD | -0.04% |
| 2010 Q3 | 1.22 Billion CAD | -2.69% |
| 2010 Q1 | 1.21 Billion CAD | -1.27% |
| 2010 Q2 | 1.25 Billion CAD | 3.17% |
| 2010 FY | 1.22 Billion CAD | -0.92% |
| 2009 Q3 | 1.24 Billion CAD | -4.19% |
| 2009 Q1 | 1.35 Billion CAD | 12.38% |
| 2009 Q2 | 1.29 Billion CAD | -4.79% |
| 2009 Q4 | 1.23 Billion CAD | -0.5% |
| 2009 FY | 1.23 Billion CAD | 2.01% |
| 2008 Q4 | 1.2 Billion CAD | 12.3% |
| 2008 Q1 | 1.06 Billion CAD | 3.46% |
| 2008 Q2 | 1.05 Billion CAD | -0.82% |
| 2008 Q3 | 1.07 Billion CAD | 2.18% |
| 2008 FY | 1.2 Billion CAD | 17.74% |
| 2007 FY | 1.02 Billion CAD | 24.83% |
| 2007 Q4 | 1.02 Billion CAD | 31.05% |
| 2007 Q3 | 784.05 Million CAD | -7.47% |
| 2007 Q2 | 847.38 Million CAD | -8.76% |
| 2007 Q1 | 928.7 Million CAD | 12.83% |
| 2006 Q2 | 755.98 Million CAD | -3.07% |
| 2006 Q3 | 796.14 Million CAD | 5.31% |
| 2006 FY | 823.12 Million CAD | 8.57% |
| 2006 Q1 | 779.93 Million CAD | 2.88% |
| 2006 Q4 | 823.12 Million CAD | 3.39% |
| 2005 Q3 | 761.6 Million CAD | -8.12% |
| 2005 FY | 758.13 Million CAD | 63.14% |
| 2005 Q1 | 814.86 Million CAD | 75.35% |
| 2005 Q2 | 828.86 Million CAD | 1.72% |
| 2005 Q4 | 758.13 Million CAD | -0.45% |
| 2004 FY | 464.7 Million CAD | -31.93% |
| 2004 Q4 | 464.7 Million CAD | -18.05% |
| 2004 Q3 | 567.08 Million CAD | -5.77% |
| 2004 Q2 | 601.8 Million CAD | -9.16% |
| 2004 Q1 | 662.49 Million CAD | -2.95% |
| 2003 Q4 | 682.65 Million CAD | -4.16% |
| 2003 FY | 682.65 Million CAD | -20.36% |
| 2003 Q1 | 779.28 Million CAD | 0.0% |
| 2003 Q2 | 720.88 Million CAD | -7.49% |
| 2003 Q3 | 712.26 Million CAD | -1.2% |
| 2002 FY | 857.13 Million CAD | 5.5% |
| 2001 FY | 812.42 Million CAD | -1.58% |
| 2000 FY | 825.44 Million CAD | -11.59% |
| 1999 FY | 933.68 Million CAD | -10.8% |
| 1998 FY | 1.04 Billion CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | -469.62 Thousand USD | 55320.728% |
| Arem Pacific Corporation | 181.02 Thousand USD | -143159.144% |
| Assisted 4 Living, Inc. | -199.71 Thousand USD | 129952.988% |
| BioCorRx Inc. | 5.56 Million USD | -4556.285% |
| Bionik Laboratories Corp. | 1.98 Million USD | -12965.071% |
| Banyan Corp. | 3.6 Million USD | -7090.538% |
| Clearday, Inc. | 44.86 Million USD | -477.989% |
| Dental Patient Care America, Inc. | -1.99 Million USD | 13086.112% |
| Quantum Medical Transport, Inc. | 1065.27 USD | -24344150.753% |
| Empower Clinics Inc. | 2.29 Million USD | -11180.96% |
| First Choice Healthcare Solutions, Inc. | 23.22 Million USD | -1016.376% |
| Selectis Health, Inc. | 35.76 Million USD | -625.162% |
| Ethema Health Corporation | 14.51 Million USD | -1686.706% |
| HealthLynked Corp. | 1.72 Million USD | -14920.504% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 13.79 Million USD | -1780.122% |
| JRSIS Health Care Corporation | 911.83 Thousand USD | -28340.734% |
| Comjoyful International Company | -28.32 Thousand USD | 915529.419% |
| Medical Facilities Corporation | 92.22 Million USD | -181.205% |
| MedSmart Group Inc. | 659.56 Thousand USD | -39218.88% |
| North America Frac Sand, Inc. | 265.41 Thousand USD | -97608.117% |
| Nova Leap Health Corp. | -686.52 Thousand USD | 37874.534% |
| Nexteligent Holdings, Inc. | 1.83 Million USD | -14007.51% |
| PAO Group, Inc. | 639.37 Thousand USD | -40460.235% |
| Primemd Inc. | 4.54 Million USD | -5607.621% |
| Raffles Medical Group Ltd | -194.49 Million USD | 233.338% |
| Ryman Healthcare Limited | 1.51 Billion USD | 82.832% |
| Stem Cell Authority, Ltd. | 15.00 USD | -1728879900.0% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.24 Million USD | -20761.381% |
| Mycotopia Therapies, Inc. | 811.51 Thousand USD | -31856.447% |
| U.S. NeuroSurgical Holdings, Inc. | -381 Thousand USD | 68166.142% |
| Veltex Corporation | 2.17 Million USD | -11799.124% |
| World Financial Holding Group | 98.11 Thousand USD | -264219.713% |
| Xcelerate Inc. | 1.18 Million USD | -21825.911% |